CARBYLAN THERAPEUTICS SCHEDULE 13D 4-24-15

Company

KalVista Pharmaceuticals, Inc.

Filed

April 24, 2015

Accession Number

0001596770-15-000036

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →